Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.47 USD | +3.89% | -3.61% | +109.04% |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Lewis
CEO | Chief Executive Officer | 54 | 17-11-30 |
Jack Callicutt
DFI | Director of Finance/CFO | 56 | 13-06-30 |
Ezra R. lowe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Pol Boudes
CTO | Chief Tech/Sci/R&D Officer | 67 | 20-03-01 |
Harold Shlevin
BRD | Director/Board Member | 75 | 12-09-30 |
Susan Thornton
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Freeman
BRD | Director/Board Member | 62 | 11-04-30 |
Benjamin Carson
BRD | Director/Board Member | 73 | 12-06 |
Gil Omenn
BRD | Director/Board Member | 83 | 14-09-22 |
Gilbert Amelio
BRD | Director/Board Member | 81 | 09-02-11 |
Harold Shlevin
BRD | Director/Board Member | 75 | 12-09-30 |
Dick Uihlein
CHM | Chairman | 79 | 17-12-13 |
Marc Rubin
BRD | Director/Board Member | 69 | 11-10-11 |
Kary Eldred
BRD | Director/Board Member | 50 | 17-12-31 |
Richard Zordani
BRD | Director/Board Member | 52 | 20-08-31 |
Elissa Schwartz
BRD | Director/Board Member | 54 | 20-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,235,000 | 0 | 0 | 67.53 % |
Stock B | 1 | 61,903,672 | 42,636,943 ( 68.88 %) | 0 | |
Stock C | 0 | 176 | 0 | 0 |
Company contact information
Galectin Therapeutics, Inc.
4960 Peachtree Industrial Boulevard Suite 240
30071, Norcross
+(678) 620-3186
http://www.galectintherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+109.04% | 207M | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- GALT Stock
- Company Galectin Therapeutics Inc.